glycyl-arginyl-glycyl-aspartyl-seryl-proline has been researched along with acetohexamide in 1 studies
| Studies (glycyl-arginyl-glycyl-aspartyl-seryl-proline) | Trials (glycyl-arginyl-glycyl-aspartyl-seryl-proline) | Recent Studies (post-2010) (glycyl-arginyl-glycyl-aspartyl-seryl-proline) | Studies (acetohexamide) | Trials (acetohexamide) | Recent Studies (post-2010) (acetohexamide) |
|---|---|---|---|---|---|
| 162 | 1 | 20 | 22 | 0 | 8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, J; Frazier, WA; Lindberg, FP; Wang, XQ | 1 |
1 other study(ies) available for glycyl-arginyl-glycyl-aspartyl-seryl-proline and acetohexamide
| Article | Year |
|---|---|
Thrombospondin-1 acts via IAP/CD47 to synergize with collagen in alpha2beta1-mediated platelet activation.
Topics: Alprostadil; Animals; Antigens, CD; Carrier Proteins; CD47 Antigen; Collagen; Detergents; Humans; Integrins; Macromolecular Substances; Mice; Oligopeptides; Peptide Fragments; Phosphorylation; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation; Protein Processing, Post-Translational; Receptors, Collagen; Thrombospondin 1 | 1999 |